• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Weight loss may decrease urinary incontinence in male diabetics [Look AHEAD Study]

byAdam SchatzandChaz Carrier
February 27, 2014
in Chronic Disease, Endocrinology, Urology
Reading Time: 3 mins read
Weight loss may decrease urinary incontinence in male diabetics [Look AHEAD Study]
Share on FacebookShare on Twitter

Image: PD 

1. Overweight or obese men with Type 2 Diabetes were shown to have decreased prevalence or resolution of urinary incontinence (UI) after one year of intensive lifestyle modification intervention (ILI). 

2. Incidence of nocturia and urinary frequency were not improved compared to diabetic support and education (DSE), suggesting ILI and weight loss might not be relevant to the pathophysiology of these symptoms. 

Evidence Rating Level: 2 (Good) 

Study Rundown: Type 2 diabetes and obesity are implicated in the development of lower urinary tract dysfunction (LUTD) in men. This study attemped to elucidate the efficacy of weight loss intervention in the resolution of such symptoms, including urinary frequency, nocturia, and urinary incontinence (UI). Intensive lifestyle intervention (ILI) included weekly meetings, both group and individual sessions. The focus of the intervention was counseling and support regarding strict calorie control, diet modification, and escalating levels of exercise. The control group received a total of three diabetic support and education (DSE) didactic sessions focused on diet, exercise, and social support opportunities. Incidence and prevalence of LUTD was measured with several symptom-based questionnaires, including baseline and one-year assessments.

The primary endpoint of the Look AHEAD study was the effect of ILI on heart disease, and follow up was terminated in 2014, as ILI was not shown to be statistically significant in regards to this endpoint. This study therefore represents only a sub-group analysis. Those exposed to ILI lost considerably more weight than the DSE group, which showed almost no improvement in this area. Symptoms of UI decreased from 11.3% to 9.0% in the ILI group and increased from 9.7% to 11.6% in the DSE group (statistically significant differences). No significant treatment effect was found for symptoms of nocturia or urinary frequency. Although this indicates that ILI may significantly affect weight loss and thereby improve weight related symptoms of LUTD in men, these findings are not generalizable to the entire diabetic population. There is no discussion of cost of this intervention or cost-benefit analysis; however, NNTB for UI appears to be approximately 5, and the benefits of exercise and dietary counselling for the obese and diabetic population are already well known. While improvements in UI symptoms may not be the primary benefit of such intervention, they may be a significant motivation for some patients.

RELATED REPORTS

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

Click to read the study in Journal of Urology

Relevant Reading: The impact of obesity on benign and malignant urologic conditions

In-Depth [randomized controlled trial]: This study enrolled 1910 men age 45-76 at 16 centers between 2001 and 2014.  All participants had diagnosed type 2 diabetes with a BMI of 25 or greater. Participants were excluded for baseline blood pressure 160/100mmHg or greater, triglycerides 600mg/dL or greater, HbA1c 11.0% or greater, a cardiovascular event within three months prior to study start, significant renal or pulmonary disease, or other conditions thought likely to limit adherence to the intervention. Baseline prevalence of UI in the population was 10.5%. Only 7% of study participants were lost to follow up. At one year the ILI group lost significantly more weight than the DSE group (9.4%+/-7.0% vs. 0.7%+/-4.5%, p < 0.001), and the ILI group had reduced prevalence of UI at one year (odds ratio (OR) 0.62, 95% confidence interval (95%CI) 0.43-0.88, p<0.01).

More from this author: Repeat Transrectal Prostate Biopsies May Increase Infection Risk; Combination therapy may improve urinary tract symptoms in BPH [CombAT Study] 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: diabetesnocturiaurinary tract dysfunction
Previous Post

PCR associated with limited diagnostic utility in viral URI

Next Post

Acetaminophen during pregnancy associated with ADHD-like behavior in children

RelatedReports

Endocrinology

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

September 10, 2026
Adalimumab aids in control of noninfectious uveitis
Chronic Disease

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

September 8, 2026
Cost-related medication nonadherence associated with increased ED utilization
Pharma

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

September 4, 2026
Weekly Rewinds

2 Minute Medicine Rewind June 29, 2026

June 29, 2026
Next Post
Acetaminophen during pregnancy associated with ADHD-like behavior in children

Acetaminophen during pregnancy associated with ADHD-like behavior in children

Mediterranean diet linked to reduced diabetes risk in high risk cardiovascular patients

Partner bereavement linked to increase acute cardiovascular events

Polio outbreak in China halted: Case report

Live MMR vaccine associated with lower hospital admissions for any infection

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar
  • Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma
  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.